After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering ...

You may not have heard of Ansys, but it's in the process of being acquired by chip design tool firm Synopsys for $35 billion.

Researchers develop machine learning tools that screen for co-morbid anxiety disorders and major depressive disorder using acoustic voice signals. The team spoke to participants with and without ...

One trend CB Insights analysts are watching is how AI is helping patients engage with health systems before the diagnostic ...

Battling a chronic disease is like running a marathon where T cells, the immune system’s frontline defenders, are the runners. When the starter’s pistol fires, the runners are fast and strong.